Skip to main content
Clinical Trials/NCT03059927
NCT03059927
Unknown
N/A

The Effect of Three Prosthesis Designs on Implant Stability and Survival, Knee Function, and Clinical Course in Knee Arthroplasty: a Randomized Trial

Lovisenberg Diakonale Hospital2 sites in 1 country216 target enrollmentMarch 1, 2017

Overview

Phase
N/A
Intervention
Not specified
Conditions
Gonarthrosis; Primary
Sponsor
Lovisenberg Diakonale Hospital
Enrollment
216
Locations
2
Primary Endpoint
Knee injury and osteoarthritis outcome score (KOOS)
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to compare three prosthesis designs to compare three prosthesis designs for total knee arthroplasty and determine the best option for patients in need of a knee replacement.

Detailed Description

Total knee arthroplasty (TKA) is a cost beneficial surgery shown to improve pain, function and quality of life in patients with osteoarthritis. In 2015, 6093 patients received primary TKA in Norway. Despite the procedure´s general success, 20% of patients report persistent postoperative pain and/or dissatisfaction with the surgical outcome. Efforts to further improve the procedure have raised considerable debate regarding the role and management of the posterior cruciate ligament (PCL). Prostheses for TKA have evolved into designs that either preserve or sacrifice the PCL. In patients with a functional PCL, the decision of which design is selected depends largely on the favor and training of the surgeon. To further improve TKA patient outcomes, a better understanding of the role of these differing PCL treatments is needed. Thus, the aim of this study is to determine whether patients' perceived outcome, implant stability and clinical outcome differ between 3 TKA implant designs (2 PCL-sacrificing and 1 PCL-retaining). We will conduct a 3-arm randomized controlled prospective trial with 5-year follow-up. This study will have impact on clinical practice by addressing the lack of evidence supporting use of these different types of implants.

Registry
clinicaltrials.gov
Start Date
March 1, 2017
End Date
December 31, 2023
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Lovisenberg Diakonale Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Primary osteoarthritis
  • Non-fixed or fixed varus or valgus deformity less than 15º measured on preoperative standing hip-knee-ankle (HKA) radiographs
  • Intact PCL (assessed preoperatively and verified during surgery)
  • Age 45 - 75 years (only patients 45 - 70 years will be included in the kinematic RSA)
  • Body mass index ≤ 35 kg/m2
  • ASA (American Society of Anaesthesiologists) score I or II
  • Only patients with KOOS scores above 80 on the Symptoms, ADL (Activities of Daily Living) and Pain subscales will be included in the kinematic analysis

Exclusion Criteria

  • Prior ACL (anterior cruciate ligament) surgery
  • Impaired collateral ligaments
  • Secondary osteoarthritis of the knee
  • Previous osteotomy
  • Rheumatic disease
  • Flexion less than 90 degrees
  • Flexion contracture over 10 degrees
  • Peripheral neuropathy
  • Malignancy
  • Patients who do not speak Norwegian

Outcomes

Primary Outcomes

Knee injury and osteoarthritis outcome score (KOOS)

Time Frame: Pre-operative, 1, 2 and 5 years

KOOS is a knee-specific questionnaire developed to evaluate short- and long-term symptoms and functioning in subjects with knee injury and osteoarthritis. KOOS is validated for use in total knee arthroplasty and has been shown to be a valid, reliable and responsive measure. KOOS is a patient-administered questionnaire.

Secondary Outcomes

  • Kinematic radiostereometric analysis (RSA)(After 12 months)
  • Plain anterior posterior radiographs and hip, knee and ankle (HKA) radiographs(Pre-operative, 3, 12, 24 and 60 months)
  • Brief Pain Inventory(Pre-operative, 6 weeks, 3, 12, 24 and 60 months)
  • Oxford knee score (OKS)(Pre-operative, 1, 2 and 5 years)
  • EQ-5D-5L(Pre-operative, 1, 2 and 5 years)
  • Range of motion (ROM)(Pre-operative, 6 weeks, 3, 12, 24 and 60 months)

Study Sites (2)

Loading locations...

Similar Trials